Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,812,468
in 11 filings, $79.8M under 10b5-1 plans

Net −$79,812,468. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-02-04 Cline Christopher R. CHIEF FINANCIAL OFFICER Sale 10b5-1 −1,635 $32.14 $53K 111,336
2026-02-04 Cline Christopher R. CHIEF FINANCIAL OFFICER Sale 10b5-1 −110 $32.90 $4K 111,226
2026-02-04 Inrig Jula CHIEF MEDICAL OFFICER Sale 10b5-1 −1,547 $32.11 $50K 105,938
2026-02-04 Inrig Jula CHIEF MEDICAL OFFICER Sale 10b5-1 −232 $32.85 $8K 105,706
2026-02-04 REED ELIZABETH E Chief Legal Officer and GC Sale 10b5-1 −2,485 $32.07 $80K 105,720
2026-02-04 REED ELIZABETH E Chief Legal Officer and GC Sale 10b5-1 −509 $32.74 $17K 105,211
2026-02-03 Cline Christopher R. CHIEF FINANCIAL OFFICER Sale −7,242 $32.12 $233K 112,971
2026-02-03 Inrig Jula CHIEF MEDICAL OFFICER Sale −6,956 $32.12 $223K 107,485
2026-02-03 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Sale −4,333 $32.12 $139K 49,080
2026-02-03 Heerma Peter CHIEF COMMERCIAL OFFICER Sale −7,310 $32.12 $235K 131,823
2026-02-03 Dube Eric M CHIEF EXECUTIVE OFFICER Sale 10b5-1 −66,452 $32.06 $2.1M 466,521
2026-02-03 Dube Eric M CHIEF EXECUTIVE OFFICER Sale 10b5-1 −33,635 $32.70 $1.1M 432,886
2026-02-03 ROTE WILLIAM E. Chief Research Officer Sale 10b5-1 −12,446 $32.87 $409K 109,087
2026-02-03 REED ELIZABETH E Chief Legal Officer and GC Sale −7,175 $32.12 $230K 108,205
2026-01-31 Cline Christopher R. CHIEF FINANCIAL OFFICER Grant or award +28,130 120,213
2026-01-31 Cline Christopher R. CHIEF FINANCIAL OFFICER Grant or award · Employee stock option (right to buy) +75,000 75,000
2026-01-31 Inrig Jula CHIEF MEDICAL OFFICER Grant or award +28,130 114,441
2026-01-31 Inrig Jula CHIEF MEDICAL OFFICER Grant or award · Employee stock option (right to buy) +75,000 75,000
2026-01-31 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Grant or award +15,180 53,413
2026-01-31 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER Grant or award · Employee stock option (right to buy) +20,160 20,160

Page 13 of 51 · 1,020 trades